Introduction
This guidance addresses the management of carpal tunnel syndrome. It needs timely treatment to prevent avoidable, irreversible and disabling loss of feeling and power.
For the purposes of differential diagnosis, when patients present with non-traumatic painful tingling of the fingers, the following should be considered alongside carpal tunnel syndrome:
 Cubital tunnel syndrome  Cervical nerve root entrapment Carpal tunnel syndrome occurs when the median nerve is compressed at the wrist in the carpal tunnel. This is the commonest form of nerve entrapment. The prevalence of carpal tunnel syndrome in the UK is 7-16%.
A UK General Practice Research Database found that 88 men and 193 women present as new cases per 100,000 population, per year (1) . Other peripheral neuropathies may coincide with carpal tunnel syndrome, and diabetes is a common co-morbidity.
Carpal tunnel syndrome is normally diagnosed in primary care and early management is usually non-surgical, whilst severe cases require surgery early
In secondary care, 52996 procedures are undertaken annually (2) .
The surgical decompression rate is 43-74 per 100,000 (3).
The proportion of carpal tunnel release procedures undertaken as day cases varies between 96.69% (4) and 99% (5) .
Cubital tunnel syndrome (6) , with tingling of the little and ring finger, is the second most common nerve entrapment in the upper limb and can rapidly weaken hand grip.
It occurs in 25 men and 19 women per 100,000 population each year (1).
High Value Care Pathway for Carpal Tunnel Syndrome
Carpal tunnel syndrome and cubital tunnel syndrome are the most common causes of tingling.
Carpal tunnel syndrome occurs due to compression of the median nerve at the wrist which causes changes in feeling of the thumb, index, middle and radial half of the ring finger.
Cubital tunnel syndrome occurs due to compression of the ulnar nerve at the elbow which causes changes in feeling of the little and ulnar half of the ring finger, with weakness of small muscles of the hand but not the thumb.  Failure of one conservative treatment is seemingly a predictor that others will also fail (8) . As such, no more than two modalities of conservative treatment should be used to avoid the risk of surgery being inappropriately delayed.
Primary Care

 Median or ulnar nerve immobilisation techniques:
o Wrist splints (wrist in neutral) at night for Carpal Tunnel Syndrome (11)  Open surgery is recommended for elderly patients and patients with multiple co-morbidities.
 Surgery should be performed:
o In an appropriate sterile operating room.
o As a day case in an ambulatory or in-patient facility, unless clinical or social circumstances dictate otherwise eg. A General Practice Surgery has a room approved for minor procedures.
o Under the supervision of a consultant surgeon who is competent to perform the surgery; supervision need only consist of annual review by a consultant surgeon based on outcome and any other audit data o Under local or regional anaesthetic, although general anaesthetic may be needed occasionally and for ulnar nerve surgery.
Patients should be informed that the decision to have surgery can be a dynamic process and a decision to not undergo surgery does not exclude them from having surgery at a future time point.
Urgent surgery is indicated where there is:
 Clinical evidence of recent denervation with persistent altered feeling.
 Sudden progression of symptoms.
 Risk of permanent irreversible nerve damage.
Other cases may be treated as routine within an 18-week framework.
Follow-up
o Patients will ordinarily require 1 follow up appointment, but there may be a clinical need for further appointments, which may be virtual.
o Identify a small minority of patients who will need hand therapy.
o Identify and manage early
Care is predominantly provided by a secondary care provider, with potential for provision of surgery in other settings where appropriate facilities are available, including access to hand therapy and appropriate nursing support.
The impact of use of independent sector providers on training and the stability of the hand unit as a whole should be considered when commissioning.
Recurrence rates after carpal tunnel decompression are between 0.3 and 12% (31) . Where complications arise, principles of continuity of care should be applied, allowing referral back to the original surgical team.
Secondary Care: Specialised Surgery
Refer to specialised secondary care provider:
 Sudden severe symptoms  Marked weakness with function deficit which may need reconstructive surgery such as tendon transfers  CRPS 1 not resolving in a fortnight  Nerve injury  Recurrent or persistent tingling after decompression
Procedures Explorer for Carpal Tunnel Syndrome
http://rcs.methods.co.uk/pet.html
The Procedures Explorer offers clinicians and commissioners an opportunity to identify variation and take action to reduce "variation in the use of health care services that cannot be explained by variation in patient illness or patient preferences" (32) . This tool covers interventions for conditions related to carpal tunnel syndrome, grouped under the phrase "painful tingling fingers", as well as carpal tunnel syndrome itself.
The Procedures Explorer Tool is available via the Royal College of Surgeons website.
The Procedures Explorer for treatment of painful tingling fingers describes variation in:
Procedure OPCS4 codes* Exclusions Carpal tunnel decompression A651 ICD10 G560 Revision carpal tunnel decompression
A691-2 with site code Z092
Cubital tunnel decompression A671, A678+Z094, A733+Z094 Ulnar nerve anterior transposition
A681, A683+Z094
Revision ulnar nerve surgery A682, A685, A691, A698, A699, with Z094 as needed ICD10 G562
Quality Dashboard for Carpal Tunnel Syndrome
The quality dashboard provides an overview of activity commissioned by CCGs from the relevant pathways, and indicators of the quality of care provided by surgical units. This tool covers interventions for conditions related to carpal tunnel syndrome, grouped under the phrase "painful tingling fingers", as well as carpal tunnel syndrome itself.
The quality dashboard is available via the Royal College of Surgeons website.
For the current dashboard indicators (see appendix 1)
Measure Definition Data Source* 1.
Standardised activity rate
Activity rate standardised for age and sex HES/Quality Dashboard appendix 1
Average length of stay
Total spell duration/total number of patients discharged HES/Quality Dashboard appendix 1
Day case rate
Number of patients admitted and discharged on the same day/total number of patients discharged HES/Quality Dashboard appendix 1
Short stay rate
Number of patients admitted and discharged within 48 hours/total number of patients discharged HES/Quality Dashboard appendix 1
7/30 day readmission rate
Number of patients readmitted as an emergency within 7/30 days of discharge/total number of patients discharged Excludes cancer, dementia, mental health HES/Quality Dashboard appendix 1
Reoperations within 30 days/1 year
Number of patients re-operated during an emergency readmission within 30 days/1 year/total number of patients discharged HES/Quality Dashboard appendix 1
In hospital mortality rate
Number of patients who die while in hospital/total number of patients discharged 
Quality Specification/CQUIN (Commissioning for Quality and Innovation)
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